Taro Pharmaceutical Industries Ltd.

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

001082718

SEDOL

2872423

CIK

0000906338

www.taro.com

LEI:

FIGI: -

TARO

Taro Pharmaceutical Industries Ltd.

GICS: - · Sector: Healthcare · Sub-Sector: Drug Manufacturers—Specialty & Generic

NAME

Taro Pharmaceutical Industries Ltd.

ISIN

IL0010827181

TICKER

TARO

MIC

XSTU

REUTERS

TARO.N

BLOOMBERG

TARO US

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.

Mon, 16.09.2024 Taro Pharmaceutical

IL0010827181

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for ...

Taro Pharmaceutical

Technical Analysis Termsheet Terminal

Permalink

Mon, 16.09.2024 Taro Pharmaceutical

IL0010827181

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company’s Offering Do...

Taro Pharmaceutical

Technical Analysis Termsheet Terminal

Permalink

Mon, 16.09.2024 Taro Pharmaceutical

IL0010827181

The sixth paragraph of the release has been replaced. The updated release reads: TARO INVESTORS HAVE OPPORTUNITY TO LEAD TARO PHARMACEUTICAL INDUSTRIES LTD. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Taro Pharmaceuti...

Taro Pharmaceutical

Technical Analysis Termsheet Terminal

Permalink

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Taro Pharmaceutical Industries Ltd.

TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm

CORRECTING and REPLACING TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm

Newsletter